Drug Shortage Report for EPIPEN JR
| Report ID | 179966 |
| Drug Identification Number | 00578657 |
| Brand name | EPIPEN JR |
| Common or Proper name | EPIPEN JR |
| Company Name | MYLAN SPECIALTY LP |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 0.15MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-04 |
| Estimated end date | 2023-01-27 |
| Actual end date | 2023-01-23 |
| Shortage status | Resolved |
| Updated date | 2023-01-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3711 COLLINS FERRY ROAD MORGANTOWN, WEST VIRGINIA UNITED STATES 26505 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-01-24 | English | Compare |
| v4 | 2023-01-23 | French | Compare |
| v3 | 2023-01-23 | English | Compare |
| v2 | 2023-01-06 | French | Compare |
| v1 | 2023-01-06 | English | Compare |
Showing 1 to 5 of 5